StockVS

Blue Water Acquisition Corp. III (BLUW) 股票分析

金融服务

Blue Water Acquisition Corp. III

$10.25

$-0.01 (-0.10%)

最后更新: 2026年5月26日

价格走势

分析

公司概述

Blue Water Acquisition Corp. III operates within the shell companies industry, focusing specifically on executing business combinations such as mergers, share exchanges, asset acquisitions, or recapitalizations within the biotechnology, healthcare, and technology sectors. The company is classified under the broader financial services sector, which distinguishes it as a special purpose acquisition vehicle (SPAC) rather than an operational entity with ongoing commercial activities. Its current market capitalization stands at $331.32 million, while the annual revenue is not available for public reporting, and the number of employees is listed as N/A. This market cap of $331.32 million indicates that the company holds a significant amount of cash relative to its stated financials, typical for SPACs awaiting a target, while the absence of revenue data reflects its pre-merger status as a vehicle designed solely for future business integration rather than current product sales.

财务健康

The company reported a net income of $-291,246 over the trailing twelve-month period, while both revenue and EBITDA figures are not available for public disclosure. The gap between the reported revenue (N/A) and the negative net income reveals a cost structure driven primarily by organizational overhead and transaction-related expenses inherent to the SPAC lifecycle, rather than operating losses from a core business. Free cash flow is not available for reporting, which implies that the company's financial flexibility is currently derived entirely from its initial public offering proceeds rather than operational cash generation. All three key margin metrics—gross margin, operating margin, and profit margin—are recorded at 0.0%, a figure that indicates the company has not yet generated revenue from commercial operations to establish a margin base. The company holds $759,229 in cash and maintains a debt level of $0, resulting in a debt-to-equity ratio that is not applicable due to the lack of equity data. This balance sheet configuration represents an extremely conservative stance with no leverage, eliminating interest obligations but also indicating that the firm is fully funded for its upcoming merger activities. Furthermore, the current ratio and return on equity (ROE) are not available, as these metrics require active revenue streams and positive equity balances that do not yet exist for this shell entity. Similarly, return on assets (ROA) is not available, preventing any assessment of management effectiveness in generating returns on the company's asset base at this stage.

估值评估

The trailing P/E ratio and forward P/E ratio are both listed as N/A, reflecting the fact that traditional earnings-based valuation multiples are not applicable to a company with negative net income and no established earnings trajectory. The price-to-book ratio stands at -40.22, a negative figure that indicates the market is valuing the company based on its net asset value and cash reserves rather than its book equity, which is often negative or minimal for SPACs prior to a deal. Price-to-sales and EV/EBITDA metrics are also N/A, suggesting that analysts must rely on alternative valuation methods such as the trust value per share or comparable SPAC transactions rather than standard enterprise valuation multiples. The stock has traded between a 52-week high of $10.41 and a 52-week low of $9.93, meaning the current price sits within a very narrow trading range close to the lower bound of its recent volatility. The beta value is N/A, which implies that the stock's price volatility relative to the broader market is difficult to quantify using standard historical regression models due to the company's unique structure and lack of historical correlation data.

Growth & Income

Revenue growth year-over-year and earnings growth year-over-year are both N/A, as the company has not yet generated positive revenue or earnings to calculate growth rates. Since the company does not pay a dividend, the dividend yield and payout ratio are N/A, indicating that any available capital is intended to be reinvested into the costs of identifying and closing a merger rather than distributed to shareholders. The absence of a dividend policy confirms that Blue Water Acquisition Corp. III follows the standard SPAC model of retaining earnings to fund the business combination transaction. Consequently, the overall growth and income profile is characterized by a complete reliance on future merger completion to unlock value, with no current organic growth drivers or income distribution mechanisms in place.

同行比较

Blue Water Acquisition Corp. III (BLUW) 在壳公司行业运营。以下是其与市值最接近的同行的比较:

公司 代码 市值 市盈率
Blue Water Acquisition Corp. III BLUW $331.16M 35.3
Twenty One Capital, Inc. XXI $2.49B N/A
Churchill Capital Corp X CCCX $711.00M N/A
Drugs Made In America Acquisition II Corp. DMII $641.46M 77.5

壳公司行业平均市盈率为82.8倍。Blue Water Acquisition Corp. III的市盈率为35.3。

本分析由AI生成,仅供参考,不构成投资建议。数据可能存在延迟或不准确。在做出投资决策之前,请务必进行自己的研究并咨询合格的财务顾问。

关于Blue Water Acquisition Corp. III

Blue Water Acquisition Corp. III does not have significant operations. The company focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses. It intends to target businesses in the artificial intelligence, biotechnology, healthcare, and technology sectors. Blue Water Acquisition Corp. III was incorporated in 2024 and is based in Mountainside, New Jersey.

公司简介以英文显示。

访问官网 →

关键指标

市值
$331.16M
市盈率
35.34
52周最高
$10.41
52周最低
$9.93
平均成交量
24.75K

数据由Yahoo Finance通过yfinance提供。每日更新。

公司信息

交易所
NASDAQ
国家
United States